Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05838313 · ClinicalTrials.gov registry record · NA

Should I Have an Elective Induction?

A NA study, sponsored by University of South Florida.

Completed
Registry status
NA
Development phase
66
Enrollment target

NCT05838313: Completed NA study, sponsored by University of South Florida.

NCT05838313 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05838313, a NA study, has completed, sponsored by University of South Florida.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target

Study Summary

The goal of the proposed study is to perform a pilot test of a patient-centered decision support tool to help pregnant people and providers work together in making informed, shared decisions regarding whether or not to opt for elective IOL at 39 weeks gestation

Primary Outcome

Recruitment rate, defined as the number of people who agree to participate out of those who are approached for the study

Interventions

  • BEHAVIORAL Elective Induction of Labor Decision Support Tool

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2023-03-22
Est. Completion 2023-09-30
Phase NA
University of South Florida

252 total trials

What the finished NCT05838313 record still lists

NCT05838313 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Elective Induction of Labor Decision Support Tool is the first listed.

NCT05838313 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05838313 about?

NCT05838313 is a clinical study titled "Should I Have an Elective Induction?". The goal of the proposed study is to perform a pilot test of a patient-centered decision support tool to help pregnant people and providers work together in making informed, shared decisions regarding whether or not to opt for elective IOL at 39 weeks gestation

What is the current status of trial NCT05838313?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2023-03-22. Estimated completion is 2023-09-30.

What interventions are being tested in trial NCT05838313?

The interventions under investigation include: Elective Induction of Labor Decision Support Tool (BEHAVIORAL).

Who is sponsoring clinical trial NCT05838313?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05838313's enrollment target sits among peer trials

66 1139th of 2000 higher than 857 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05838313, the US trial registry maintained by the National Library of Medicine. NCT05838313 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.